Fourteen projects receiving funding to support R&D, innovation in addressing challenges in therapeutic delivery and unlocking potential of data science to answer pressing life sciences questions
Today, the Baker-Polito Administration and the Massachusetts Life Sciences Center (MLSC) announced more than $18 million in capital funding to support 14 projects by advancing life sciences R&D, innovations in therapeutic delivery and unlocking potential of data science to answer pressing life sciences questions. The MLSC is awarding this funding through its capital programming portfolio, specifically its Research Infrastructure, Novel Therapeutics Delivery, and Bits to Bytes programs.
“Point of care ultrasound technology enables physicians to obtain critical diagnostic information of patients immediately at the bedside yet only a small fraction of medical doctors in Massachusetts have point-of-care ultrasound training,” said Andrew Goldsmith, MD, MBA, Director of Emergency Ultrasound at Brigham and Women’s Hospital and Instructor at Harvard Medical School. “With this funding, our Brigham and Women’s team with Centaur Labs – a leading provider of medical data labeling – will develop multiple AI applications for point of care ultrasound and revolutionize the way we deliver care.”
Listen to Co-founder and CEO Erik Duhaime talk about the origins of Centaur Labs and the future of medical data labeling.